Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems

Por Viktil, Kirsten K, Blix, Hege S, Moger, Tron A, Reikvam, Aasmund
Publicado em 2007

Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients

Por Blix, Hege S., Viktil, Kirsten K., Moger, Tron A., Reikvam, Aasmund
Publicado em 2010

Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients

Por Hege S. BLIX, Kirsten K. VIKTIL, Tron A. MOGER, Aasmund REIKVAM
Publicado no Pharmacy Practice (2010)

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study

Por Conrozier, T., Saxne, T., Fan, C. S., Mathieu, P., Tron, A., Heinegard, D., Vignon, E.
Publicado em 1998

Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations

Por Haugen, Marion, Bray, Freddie, Grotmol, Tom, Tretli, Steinar, Aalen, Odd O., Moger, Tron A.
Publicado em 2009

How are drug regimen changes during hospitalisation handled after discharge: a cohort study

Por Viktil, Kirsten K, Blix, Hege Salvesen, Eek, Anne Katrine, Davies, Maren Nordsveen, Moger, Tron A, Reikvam, Aasmund
Publicado em 2012

Computational mouse atlases and their application to automatic assessment of craniofacial dysmorphology caused by the Crouzon mutation Fgfr2(C342Y)

Por Ólafsdóttir, Hildur, Darvann, Tron A, Hermann, Nuno V, Oubel, Estanislao, Ersbøll, Bjarne K, Frangi, Alejandro F, Larsen, Per, Perlyn, Chad A, Morriss-Kay, Gillian M, Kreiborg, Sven
Publicado em 2007